Catalog Home Page

Genomic testing as a tool to optimise drug therapy

Somogyi, A.A. and Phillips, E. (2017) Genomic testing as a tool to optimise drug therapy. Australian Prescriber, 40 (3). pp. 101-104.

[img]
Preview
PDF - Published Version
Download (117kB) | Preview
Link to Published Version: https://doi.org/10.18773/austprescr.2017.027
*Subscription may be required
Free to read: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC54783...
*No subscription required

Abstract

A person’s genetic make-up, including their ethnicity, can affect how they respond to a drug. It can also contribute to drug toxicity and efficacy.

Pharmacogenomic testing is now inexpensive, relatively fast and can enhance patient care.

Pre-emptive tests for azathioprine and abacavir are subsidised by Medicare.

A national regulatory system including standardised reporting and guidelines for interpreting test results is urgently needed. Improved education for GPs and pharmacists at postgraduate and undergraduate levels is also needed.

Publication Type: Journal Article
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Publisher: NPS
Copyright: © 2016 NPS MedicineWise
URI: http://researchrepository.murdoch.edu.au/id/eprint/38014
Item Control Page Item Control Page

Downloads

Downloads per month over past year